ONWARD MEDICAL NV | WebDisclosure

PRESS RELEASE

published on 09/02/2025 at 07:47, 5 months 18 days ago

ONWARD Medical Demonstrates Commercial Traction and Advances Pipeline in the First Half of 2025
ONWARD Medical showcases commercial progress and advances pipeline in the first half of 2025, meeting sales targets, achieving regulatory milestones, and demonstrating science & technology leadership

Neurotechnology Pipeline Regulatory Milestones ONWARD Medical Commercial Traction
BRIEF

published on 08/18/2025 at 18:45, 6 months 2 days ago

ONWARD Medical obtient le feu vert de la FDA pour l'étude Empower BP

Approbation De La FDA ONWARD Medical Lésion De La Moelle Épinière Étude Empower BP Système ARC-IM
BRIEF

published on 08/18/2025 at 18:45, 6 months 2 days ago

ONWARD Medical Secures FDA IDE Green Light for Empower BP Study

FDA Approval ONWARD Medical Spinal Cord Injury Empower BP Study ARC-IM System
PRESS RELEASE

published on 08/18/2025 at 18:40, 6 months 2 days ago

ONWARD Medical Receives FDA IDE Approval to Initiate the Empower BP Pivotal Study with the ARC-IM System
ONWARD Medical receives FDA IDE approval for ARC-IM System to address blood pressure instability after SCI with upcoming Empower BP pivotal study involving 20 global research centers

SCI ONWARD Medical ARC-IM System FDA IDE Approval Blood Pressure Instability
BRIEF

published on 08/06/2025 at 08:57, 6 months 14 days ago

ONWARD Medical nomme Lucas Buchanan au conseil d'administration

Conseil D'administration ONWARD Medical Neurotechnologie Lésion De La Moelle Épinière Lucas Buchanan
BRIEF

published on 08/06/2025 at 08:57, 6 months 14 days ago

ONWARD Medical Appoints Lucas Buchanan to Board of Directors

Board Of Directors Neurotechnology ONWARD Medical Spinal Cord Injury Lucas Buchanan
PRESS RELEASE

published on 08/06/2025 at 08:52, 6 months 14 days ago

ONWARD Medical Announces the Appointment of Lucas Buchanan to its Board of Directors
ONWARD Medical appoints Lucas Buchanan, former CFO/COO of Silk Road Medical, as non-executive board member in a strategic move to advance company growth and mission

Board Of Directors Medical Device Neurotechnology ONWARD Medical Lucas Buchanan
BRIEF

published on 07/07/2025 at 13:57, 7 months 13 days ago

ONWARD Medical accueille Tim Denison au sein de son conseil d'administration

Conseil D'administration ONWARD Medical Neurotechnologie Tim Denison Lésion De La Moelle Épinière
BRIEF

published on 07/07/2025 at 13:57, 7 months 13 days ago

ONWARD Medical Welcomes Tim Denison to Board of Directors

Board Of Directors Neurotechnology ONWARD Medical Tim Denison Spinal Cord Injury
PRESS RELEASE

published on 07/07/2025 at 13:52, 7 months 13 days ago

ONWARD Medical Adds Entrepreneur and Neurotechnology Thought Leader Tim Denison, PhD to its Board of Directors
ONWARD Medical appoints neurotechnology thought leader Tim Denison, PhD to Board of Directors, as Professor Gregoire Courtine transitions to new roles. Company announces additional Board appointments and reappointments

Board Of Directors Neurotechnology ONWARD Medical Tim Denison Gregoire Courtine

Published on 02/20/2026 at 20:15, 17 minutes ago

Lithium South Announces Results of its Annual and Special Meeting of Securityholders
Published on 02/20/2026 at 20:15, 17 minutes ago

Verdera Energy Announces Closing of Qualifying Transaction
Published on 02/20/2026 at 18:30, 2 hours 2 minutes ago

Sparta Updates Delay in Filing Annual Financial Statements
Published on 02/20/2026 at 15:45, 4 hours 47 minutes ago

Revolve Announces Closing of Initial US$10 Million Advance on Strategic Financing With Callaway
Published on 02/20/2026 at 14:30, 6 hours 2 minutes ago

Norse Gold Announces Application for Reactivation to TSX-V, Private Placement Financing and Stock Options Grant

View all ACCESSWIRE

Published on 02/20/2026 at 18:36, 1 hour 55 minutes ago

EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 2 hours 1 minute ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:23, 2 hours 9 minutes ago

POS-Transaction in Own Shares
Published on 02/20/2026 at 18:00, 2 hours 32 minutes ago

Leclanché conclut un accord de financement d’un montant de CHF 16,7 millions pour soutenir ses opérations à court terme
Published on 02/20/2026 at 18:00, 2 hours 32 minutes ago

Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations

View all EQS

Published on 02/20/2026 at 19:29, 1 hour 3 minutes ago

SFPI GROUP: Liquidity agreement report S2 2025
Published on 02/20/2026 at 19:29, 1 hour 3 minutes ago

SFPI GROUP: bilan du contrat de liquidité S2 S025
Published on 02/20/2026 at 18:00, 2 hours 32 minutes ago

TERACT - Termination of liquidity agreement
Published on 02/20/2026 at 18:00, 2 hours 32 minutes ago

TERACT - Résiliation du contrat de liquidité
Published on 02/20/2026 at 17:35, 2 hours 57 minutes ago

CHIFFRE D'AFFAIRES 2025

View all LES ECHOS COMFI WIRE

News